$24.41
+0.97 (+4.14%)
Open$23.81
Previous Close$23.44
Day High$24.42
Day Low$23.50
52W High$31.37
52W Low$4.66
Volume—
Avg Volume319.9K
Market Cap1.21B
P/E Ratio—
EPS$-1.51
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+84.2% upside
Current
$24.41
$24.41
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.93M | 203.59M | 209.55M |
| Net Income | -329,262,508 | 62.98M | 65.23M |
| Profit Margin | -6,678.9% | 30.9% | 31.1% |
| EBITDA | -364,639,131 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |